I won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetI'm ashareholdermyselfMino-WrapWe had aphase 2btrial with100%efficacyOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mMino-Lokpotentialmarket>$1BMino-Lokis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We will openupinternationalsites forMino-Lok trialThere are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeAn actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013I/ONTAK'spotentialmarket is>$300mI won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetI'm ashareholdermyselfMino-WrapWe had aphase 2btrial with100%efficacyOnly biotechwith 2 Myron'son theleadershipteamInsidersinvested$26.5mMino-Lokpotentialmarket>$1BMino-Lokis our leadassetI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We will openupinternationalsites forMino-Lok trialThere are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeAn actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013I/ONTAK'spotentialmarket is>$300m

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I won't dilute shareholders
  2. Our Halo-Lido trial will have final patient by end of 2022
  3. We expect to finish the Mino-Lok trial this year
  4. Hemorrhoids is a $2B market
  5. Not many companies this size with 2 late stage assets
  6. We have enough cash to go well into 2023
  7. I/ONTAK is our lead asset
  8. I'm a shareholder myself
  9. Mino-Wrap
  10. We had a phase 2b trial with 100% efficacy
  11. Only biotech with 2 Myron's on the leadership team
  12. Insiders invested $26.5m
  13. Mino-Lok potential market >$1B
  14. Mino-Lok is our lead asset
  15. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  16. We will have exclusivity
  17. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  18. We will open up international sites for Mino-Lok trial
  19. There are no FDA approved drugs to treat hemorrhoids
  20. We intend to submit a BLA in 2H 2022
  21. I/ONTAK was the best deal I ever made
  22. An actual iMSC update
  23. Myron Holubiak and I founded a private company in 2013
  24. I/ONTAK's potential market is >$300m